Clinical TrialsSearch results
Number of results: 1202
Other
- A multicentre study on clinical usefulness of urinary trypsinogen-2 for early diagnosis of acute pancreatitis.
- Definite or possible acute pancreatitis.
- Division of Gastroenterology, Tohoku University Graduate School of Medicine
- 2009-01-07
Completed
- A Non Interventional Pilot Study on Machine Learning for ILD detection based on the patient data from digital devices in unresectable stage III Non-Small Cell Lung Cancer Patients receiving durvalumab
- Non-Small Cell Lung Cancer
- Kouda Shigetaka
- 2021-06-02
Completed
- A non-interventional, single-arm, multicentre, prospective study investigating the glycaemic control and treatment pattern associated with the use of Xultophy (IDegLira) in a real-world adult population with type 2 diabetes mellitus in Japan.(NN9068-4743)
- Type 2 Diebetes Mellitus
- Sudoh Yuki
- 2021-04-21
Other
- A non-randomized confirmatory study of Limited Surgical Resection for Peripheral Early Lung Cancer Defined with Thoracic Thin-section Computed Tomography (JCOG0804/WJOG4507L)
- small (2 cm or less) peripheral radiological non-invasive lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-05-26
Completed
- A Phase 1 study of BFKB8488A in Japanese NAFLD patients.
- nonalcoholic fatty liver disease
- Nanki Toshihiro
- 2021-04-09
Other
- A phase 1 study of the combination chemotherapy of sorafenib with cisplatin transcatheter arterial infusion for advanced hepatocellular carcinoma.
- advanced hepatocellular carcinoma
- National Cancer Center Hospital
- 2008-12-02
Completed
- A phase 1 study of VLPCOV-01 in COVID-19 vaccinated healthy subjects
- Prevention of infectious disease caused by SARS-CoV-2
- Nobuaki Sato
- 2022-02-01
Other
- A Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of TIN816 in Japanese healthy participants
- Healthy participants
- Maruyama Hideki
- 2023-09-27
Other
- A Phase 1 Study to evaluate tolerability, safety and efficacy of AB122 and AB154 in Combination with Chemotherapy for Patients With Non-Small Cell Lung Cancer
- First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer
- Nasermoaddeli Ali
- 2023-04-11
Completed
- A phase 1/2 trial of booster dose of VLPCOV-02 vaccine
- Prevention of infectious disease caused by SARS-CoV-2
- Aboshi Masayuki
- 2023-04-10